Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2440721
Max Phase: Preclinical
Molecular Formula: C20H32N4O3S
Molecular Weight: 408.57
Molecule Type: Small molecule
Associated Items:
ID: ALA2440721
Max Phase: Preclinical
Molecular Formula: C20H32N4O3S
Molecular Weight: 408.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCNC(=S)Nc1cc(/C=C/C(=O)NO)ccc1OCCN(CC)CC
Standard InChI: InChI=1S/C20H32N4O3S/c1-4-7-12-21-20(28)22-17-15-16(9-11-19(25)23-26)8-10-18(17)27-14-13-24(5-2)6-3/h8-11,15,26H,4-7,12-14H2,1-3H3,(H,23,25)(H2,21,22,28)/b11-9+
Standard InChI Key: ANZLOLYTGQBPAB-PKNBQFBNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 408.57 | Molecular Weight (Monoisotopic): 408.2195 | AlogP: 3.01 | #Rotatable Bonds: 12 |
Polar Surface Area: 85.86 | Molecular Species: BASE | HBA: 5 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.74 | CX Basic pKa: 9.09 | CX LogP: 2.69 | CX LogD: 1.38 |
Aromatic Rings: 1 | Heavy Atoms: 28 | QED Weighted: 0.14 | Np Likeness Score: -1.19 |
1. Ning C, Bi Y, He Y, Huang W, Liu L, Li Y, Zhang S, Liu X, Yu N.. (2013) Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors., 23 (23): [PMID:24119555] [10.1016/j.bmcl.2013.09.051] |
Source(1):